Irene De Simone
Istituto Di Ricerche Farmacologiche Mario Negri
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Irene De Simone as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:35 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04794127 · Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.Mario Negri Institute for Pharmacological Research · completed · Liposarcoma, Myxoid, Liposarcoma, Dedifferentiated, Liposarcoma, Round Cell · study chair
- Ph3NCT04776655 · Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaBAzienda USL Reggio Emilia - IRCCS · active not recruiting · Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.